What people are saying - Write a review
We haven't found any reviews in the usual places.
adverse reactions antibody assess Austrian bacteremia biological products BOB’s Bureau capsular Center for Disease clinical trials coccal compensation conducted Congress Connaught Laboratories cost-effectiveness analysis costs Davis and Company Diphtheria Drug duty to warn effects epidemiologic establish evaluate the safety factors Federal Government funds Guillain-Barre Syndrome high risk Immunogenicity incidence individuals infection influenza investigators Lederle Laboratories licensed vaccines licensure measles Medicare Merck Sharp million NIAID option OTA’s analysis patients percent physicians pneu pneumo pneumococcal disease pneumococcal pneumonia pneumococcal polysaccharide vaccine pneumococcal vaccine policies polio polysaccharide vaccine polyvalent population postmarketing potential premarketing clinical trials preventive private sector product license Public Health public immunization programs QALY reported safety and efficacy Sharp and Dohme studies swine flu testing tion types of pneumococci Types of Vaccine vaccination programs vaccine manufacturers vaccine products vaccine research vaccine safety vaccine-related injuries
Page xiii - Efficacy: The probability of benefit to individuals in a defined population from a medical technology applied for a given medical problem under ideal conditions of use.
Page 180 - ... to 9,000 Medicare beneficiaries with organ transplants will approach $35 million in 1987, or about $4,000 per beneficiary. Immunizations are covered only in specific circumstances: vaccination against pneumococcal pneumonia and hepatitis B (for those at medium or high risk only) and immunization directly related to the treatment of an injury or direct exposure to a disease or condition such as rabies or tetanus. Most immunizations, such as for smallpox and influenza, are not covered. Medicare...
Page 26 - T_ a s. [Page Omitted] This page was originally printed on a gray background. The scanned version of the page is almost entirely black and is unusable. It has been intentionally omitted. If a replacement page image of higher quality becomes available, it will be posted within the copy of this report found on one of the OTA websites.
Page xiv - Medical technology: The drugs, devices, and medical and surgical procedures used in medical care, and the organizational and supportive systems within which such care is provided.
Page vi - University Robert M. Ball Senior Scholar Institute of Medicine National Academy of Sciences Lewis H.
Page 92 - ... ...Statistically predictable as are these rare cases of vaccine-induced polio, a strong argument can be advanced that the loss ought not lie where it falls (on the victim), but should be borne by the manufacturer as a foreseeable cost of doing business, and passed on to the public in the form of price increases to his customers.
Page 64 - And program budgeting at the highest levels leaves pure efficiency far behind its overreaching grasp into the structure of the political system. Program budgeting, it turns out, is a form of systems analysis, that is, political systems analysis. These modes of analysis are neither good for nothing nor good for everything, and one cannot speak of them as wholly good or bad. It is much more useful to try to specify some conditions under which they would or would not be helpful for various purposes....
Page vii - Hospital of San Francisco John D. Chase Associate Dean for Clinical Affairs University of Washington School of Medicine Joseph Fletcher Visiting Scholar Medical Ethics School of Medicine University of Virginia Clark C. Havighurst Professor of Law School of Law Duke University Sheldon Leonard...
Page 164 - ... experiences that may influence a determination as to the effectiveness of combinations of the individual active components. 5. Pertinent medical and scientific literature. C. Finished biological product. 1. Controlled studies. 2. Partially controlled or uncontrolled studies. 3. Documented case reports. 4. Pertinent marketing experiences that may influence a determination as to the effectiveness of the finished biological product.